Literature DB >> 33981636

Texture Analysis Based on Gd-EOB-DTPA-Enhanced MRI for Identifying Vessels Encapsulating Tumor Clusters (VETC)-Positive Hepatocellular Carcinoma.

Yanfen Fan1,2, Yixing Yu1,2, Ximing Wang1,2, Mengjie Hu1,2, Mingzhan Du3, Lingchuan Guo3, Shifang Sun4, Chunhong Hu1,2.   

Abstract

PURPOSE: To determine the potential findings associated with vessels encapsulating tumor clusters (VETC)-positive hepatocellular carcinoma (HCC), with particular emphasis on texture analysis based on gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI.
METHODS: Eighty-one patients with VETC-negative HCC and 52 patients with VETC-positive HCC who underwent Gd-EOB-DTPA-enhanced MRI before curative partial hepatectomy were retrospectively evaluated in our institution. MRI texture analysis was performed on arterial phase (AP) and hepatobiliary phase (HBP) images. The least absolute shrinkage and selection operator (LASSO) logistic regression was used to select texture features most useful for identifying VETC-positive HCC. Univariate and multivariate analyses were used to determine significant variables for identifying the VETC-positive HCC in clinical factors and the texture features of MRI. Receiver operating characteristic (ROC) analysis and DeLong test were performed to compare the identified performances of significant variables for identifying VETC-positive HCC.
RESULTS: LASSO logistic regression selected 3 features in AP and HBP images, respectively. In multivariate analysis, the Log-sigma-4.0-mm-3D first-order Kurtosis derived from AP images (odds ratio [OR] = 4.128, P = 0.001) and the Wavelet-LHL-GLDM Dependence Non Uniformity Normalized derived from HBP images (OR = 2.280, P = 0.004) were independent significant variables associated with VETC-positive HCC. The combination of the two texture features for identifying VETC-positive HCC achieved an AUC value of 0.844 (95% confidence interval CI, 0.777, 0.910) with a sensitivity of 80.8% (95% CI, 70.1%, 91.5%) and specificity of 74.1% (95% CI, 64.5%, 83.6%).
CONCLUSION: Texture analysis based on Gd-EOB-DTPA-enhanced MRI can help identify VETC-positive HCC.
© 2021 Fan et al.

Entities:  

Keywords:  GD-EOB-DTPA; VETC; hepatocellular carcinoma; quantitative; texture analysis

Year:  2021        PMID: 33981636      PMCID: PMC8108126          DOI: 10.2147/JHC.S293755

Source DB:  PubMed          Journal:  J Hepatocell Carcinoma        ISSN: 2253-5969


  29 in total

1.  Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].

Authors: 
Journal:  J Hepatol       Date:  2019-02-07       Impact factor: 25.083

2.  A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.

Authors:  Wentao Wang; Dongsheng Gu; Jingwei Wei; Ying Ding; Li Yang; Kai Zhu; Rongkui Luo; Sheng-Xiang Rao; Jie Tian; Mengsu Zeng
Journal:  Eur Radiol       Date:  2020-01-30       Impact factor: 5.315

3.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.

Authors:  Jorge A Marrero; Laura M Kulik; Claude B Sirlin; Andrew X Zhu; Richard S Finn; Michael M Abecassis; Lewis R Roberts; Julie K Heimbach
Journal:  Hepatology       Date:  2018-08       Impact factor: 17.425

4.  Edmondson-Steiner grade: A crucial predictor of recurrence and survival in hepatocellular carcinoma without microvascular invasio.

Authors:  Li Zhou; Jing-An Rui; Wei-Xun Zhou; Shao-Bin Wang; Shu-Guang Chen; Qiang Qu
Journal:  Pathol Res Pract       Date:  2017-03-08       Impact factor: 3.250

5.  Magnetic resonance texture analysis for the identification of cytokeratin 19-positive hepatocellular carcinoma.

Authors:  He-Qing Wang; Chun Yang; Meng-Su Zeng; Sheng-Xiang Rao; Yuan Ji; Xin Weng; Ji-Yong Wang; Ruo-Fan Sheng
Journal:  Eur J Radiol       Date:  2019-06-18       Impact factor: 3.528

6.  A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.

Authors:  Jian-Hong Fang; Hui-Chao Zhou; Chong Zhang; Li-Ru Shang; Lei Zhang; Jing Xu; Limin Zheng; Yunfei Yuan; Rong-Ping Guo; Wei-Hua Jia; Jing-Ping Yun; Min-Shan Chen; Yaojun Zhang; Shi-Mei Zhuang
Journal:  Hepatology       Date:  2015-04-22       Impact factor: 17.425

7.  Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.

Authors:  Sébastien Mulé; Athena Galletto Pregliasco; Arthur Tenenhaus; Rym Kharrat; Giuliana Amaddeo; Laurence Baranes; Alexis Laurent; Hélène Regnault; Daniele Sommacale; Marjane Djabbari; Frédéric Pigneur; Vania Tacher; Hicham Kobeiter; Julien Calderaro; Alain Luciani
Journal:  Radiology       Date:  2020-03-31       Impact factor: 11.105

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Resection of hepatocellular cancer ≤2 cm: results from two Western centers.

Authors:  Sasan Roayaie; Khaled Obeidat; Carlo Sposito; Luigi Mariani; Sherrie Bhoori; Alessandro Pellegrinelli; Daniel Labow; Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Hepatology       Date:  2013-01-25       Impact factor: 17.425

10.  Computational Radiomics System to Decode the Radiographic Phenotype.

Authors:  Joost J M van Griethuysen; Andriy Fedorov; Chintan Parmar; Ahmed Hosny; Nicole Aucoin; Vivek Narayan; Regina G H Beets-Tan; Jean-Christophe Fillion-Robin; Steve Pieper; Hugo J W L Aerts
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

View more
  3 in total

1.  Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.

Authors:  Renguo Guan; Wenping Lin; Jingwen Zou; Jie Mei; Yuhua Wen; Lianghe Lu; Rongping Guo
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

Review 2.  Progress of MRI Radiomics in Hepatocellular Carcinoma.

Authors:  Xue-Qin Gong; Yun-Yun Tao; Yao-Kun Wu; Ning Liu; Xi Yu; Ran Wang; Jing Zheng; Nian Liu; Xiao-Hua Huang; Jing-Dong Li; Gang Yang; Xiao-Qin Wei; Lin Yang; Xiao-Ming Zhang
Journal:  Front Oncol       Date:  2021-09-20       Impact factor: 6.244

Review 3.  Magnetic Fields and Cancer: Epidemiology, Cellular Biology, and Theranostics.

Authors:  Massimo E Maffei
Journal:  Int J Mol Sci       Date:  2022-01-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.